International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 4 , Pages 854-861 , 15 July 2002

Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation

  • Hans Kristian Haugland, M.D., Ph.D.

      Affiliations

    • Department of Medical Biophysics, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada
  • ,
  • Vojislav Vukovic, M.D., Ph.D.

      Affiliations

    • Department of Medical Biophysics, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada
  • ,
  • Melania Pintilie, M.Sc.

      Affiliations

    • Department of Biostatistics, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada
  • ,
  • Anthony W Fyles, M.D.

      Affiliations

    • Department of Radiation Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada
  • ,
  • Michael Milosevic, M.D.

      Affiliations

    • Department of Radiation Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada
  • ,
  • Richard P Hill, Ph.D.

      Affiliations

    • Department of Medical Biophysics, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada
  • ,
  • David W Hedley, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: David W. Hedley, M.D., Department of Medical Biophysics, Ontario Cancer Institute/Princess Margaret Hospital, 610 University Ave., Toronto, Ontario M5G 2M9 Canada. Tel: 416-946-2262; Fax: 416-946-2984
    • Department of Medical Biophysics, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada
    • Department of Medical Oncology and Hematology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada
    • Department of Oncologic Pathology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada

Received 8 October 2001 ,Revised 4 February 2002 ,Accepted 27 February 2002.

References 

  1. Hockel M, Schlenger K, Aral B, et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56:4509–4515
  2. Fyles AW, Milosevic M, Wong R, et al.  Oxygenation predicts radiation response and survival in patients with cervix cancer. [published erratum appears in Radiother Oncol 1999;50:371] Radiother Oncol. 1998;48:149–156
  3. Brizel DM, Scully SP, Harrelson JM, et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996;56:941–943
  4. Brizel DM, Sibley GS, Prosnitz LR, et al.  Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285–289
  5. Rofstad EK. Microenvironment-induced cancer metastasis. [In Process Citation] Int J Radiat Biol. 2000;76:589–605
  6. Dachs GU, Stratford IJ. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br J Cancer Suppl. 1996;27:S126–S132
  7. Sutherland RM, Ausserer WA, Murphy BJ, et al.  Tumor hypoxia and heterogeneity (Challenges and opportunities for the future). Semin Radiat Oncol. 1996;6:59–70
  8. Blancher C, Harris AL. The molecular basis of the hypoxia response pathway (Tumor hypoxia as a therapy target). Cancer Metastasis Rev. 1998;17:187–194
  9. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995;270:1230–1237
  10. Wenger RH. Mammalian oxygen sensing, signaling and gene regulation. J Exp Biol. 2000;203:1253–1263
  11. Jiang BH, Semenza GL, Bauer C, et al.  Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol. 1996;271:C1172–C1180
  12. Huang LE, Gu J, Schau M, et al.  Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1998;95:7987–7992
  13. Kallio PJ, Wilson WJ, O’Brien S, et al.  Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem. 1999;274:6519–6525
  14. Semenza GL, Jiang BH, Leung SW, et al.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 1996;271:32529–32537
  15. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447–5454
  16. Forsythe JA, Jiang BH, Iyer NV, et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604–4613
  17. Gerber HP, Condorelli F, Park J, et al.  Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes (Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia). J Biol Chem. 1997;272:23659–23667
  18. Feldser D, Agani F, Iyer NV, et al.  Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 1999;59:3915–3918
  19. Evans SM, Hahn S, Pook DR, et al.  Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 2000;60:2018–2024
  20. Varia MA, Calkins-Adams DP, Rinker LH, et al.  Pimonidazole (A novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma). Gynecol Oncol. 1998;71:270–277
  21. Wijffels KI, Kaanders JH, Rijken PF, et al.  Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. [In Process Citation] Br J Cancer. 2000;83:674–683
  22. Talks KL, Turley H, Gatter KC, et al.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 2000;157:411–421
  23. Grambsch P, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–526
  24. Hockel M, Knoop C, Schlenger K, et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 1993;26:45–50
  25. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1996;41:31–39
  26. Zhong H, De Marzo AM, Laughner E, et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999;59:5830–5835
  27. Zagzag D, Zhong H, Scalzitti JM, et al.  Expression of hypoxia-inducible factor 1alpha in brain tumors (Association with angiogenesis, invasion, and progression). Cancer. 2000;88:2606–2618
  28. Vukovic V, Haugland HK, Nicklee T, et al.  Hypoxia-inducible factor-1α is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res. 2001;61:7394–7398
  29. Wang GL, Jiang BH, Rue EA, et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510–5514
  30. Huang LE, Arany Z, Livingston DM, et al.  Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem. 1996;271:32253–32259
  31. Rijken PF, Bernsen HJ, Peters JP, et al.  Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft (A quantitative multi-parameter analysis). (1) Int J Radiat Oncol Biol Phys. 2000;48:571–582
  32. Birner P, Schindl M, Obermair A, et al.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000;60:4693–4696
  33. Thrall DE, Rosner GL, Azuma C, et al.  Hypoxia marker labeling in tumor biopsies (Quantification of labeling variation and criteria for biopsy sectioning). Radiother Oncol. 1997;44:171–176

 Supported by the National Cancer Institute of Canada, using funds raised by the Terry Fox run.

PII: S0360-3016(02)02815-8

International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 4 , Pages 854-861 , 15 July 2002